This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guinea, J.
Right arrow Articles by Bouza, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guinea, J.
Right arrow Articles by Bouza, E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2005, p. 3495-3497, Vol. 49, No. 8
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.8.3495-3497.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Antifungal Susceptibility of 596 Aspergillus fumigatus Strains Isolated from Outdoor Air, Hospital Air, and Clinical Samples: Analysis by Site of Isolation

J. Guinea, T. Peláez, L. Alcalá,* M. J. Ruiz-Serrano, and E. Bouza

Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario "Gregorio Marañón," University of Madrid, Spain

Received 4 April 2005/ Returned for modification 30 April 2005/ Accepted 19 May 2005

We analyzed the activities of six antifungal drugs (amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin, and micafungin) against 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples. We did not find differences among the susceptibilities by site of isolation.

* Corresponding author. Mailing address: Servicio de Microbiología, Hospital Universitario Gregorio Marañón, Calle Doctor Esquerdo, 46, 28007 Madrid, Spain. Phone: 34915868453. Fax: 34915044906. E-mail: luisalcala{at}efd.net.

Antimicrobial Agents and Chemotherapy, August 2005, p. 3495-3497, Vol. 49, No. 8
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.8.3495-3497.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Monzon, A., Buitrago, M. J., Rodriguez-Tudela, J. L. (2009). Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds. Antimicrob. Agents Chemother. 53: 2192-2195 [Abstract] [Full Text]  
  • Guinea, J., Recio, S., Pelaez, T., Torres-Narbona, M., Bouza, E. (2008). Clinical Isolates of Aspergillus Species Remain Fully Susceptible to Voriconazole in the Post-Voriconazole Era. Antimicrob. Agents Chemother. 52: 3444-3446 [Abstract] [Full Text]  
  • Guinea, J., Pelaez, T., Recio, S., Torres-Narbona, M., Bouza, E. (2008). In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species. Antimicrob. Agents Chemother. 52: 1396-1400 [Abstract] [Full Text]  
  • Olson, J. A., Adler-Moore, J. P., Schwartz, J., Jensen, G. M., Proffitt, R. T. (2006). Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.. Antimicrob. Agents Chemother. 50: 2122-2131 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»